PSMA-Based Radioligand Therapy for Metastatic Castration-Resistant Prostate Cancer: The Bad Berka Experience Since 2013
Figure 2: 68Ga-PSMA-HBED-CC PET/CT before and after treatment with 177...
Novel radionuclide therapy proven safe and effective to treat neuroendocrine neoplasms
PSMA Theranostics in Prostate Cancer SNMMI - Richard Baum
Reassessment of somatostatin receptor SST4 expression in bronchopulmonary and gastroenteropancreatic neuroendocrine neoplasms using the novel rabbit monoclonal anti-human SST4 antibody 7H49L61
Figure 8.-68 Ga-PSMA PET/CT following therapy with [ 177 Lu]PSMA I&T....
Robag Wruhme: “If the ideas don’t come up, even the best setup is useless”
Theranostics: a new hope in the fight against cancer
Serum Vasoactive Intestinal Peptide as a Novel Biomarker for Low‐Voltage Areas in Patients With Atrial Fibrillation
New hope in the fight against prostate cancer: ‘We can win this war’
Steven Louis Schmidt
Expression of G protein-coupled receptor GPR19 in normal and neoplastic human tissues
New PET radiotracer proven safe and effective in imaging malignant brain tumors
First-in-Humans Study of the SSTR Antagonist 177Lu-DOTA-LM3 for Peptide Receptor Radionuclide Therapy in Patients with Metastatic Neuroendocrine Neoplasms: Dosimetry, Safety, and Efficacy
Early treatment of advanced prostate cancer with radioligand therapy prolongs life
Prognosis and quality of life in patients with locally advanced rectal cancer after abdominoperineal resection in the CAO/ARO/AIO-04 randomized phase 3 trial
177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer Patients with a Single Functioning Kidney
Different somatostatin and CXCR4 chemokine receptor expression in gastroenteropancreatic neuroendocrine neoplasms depending on their origin
Parameters to Predict Progression-Free and Overall Survival After Peptide Receptor Radionuclide Therapy: A Multivariate Analysis in 782 Patients
Guideline for the management of neurogenic bowel dysfunction in spinal cord injury/disease
Blood test predicts success of neuroendocrine cancer therapy
Transcatheter Aortic Valve Replacement Without the Use of Contrast Medium: An Alternative Safe Implantation Technique
Intermittent colonic exoperistalsis for chronic constipation in spinal cord-injured individuals. A long-term structured patient feedback survey to evaluate home care use
A Prospective, Randomized, Double-Blind Study to Evaluate the Safety, Biodistribution, and Dosimetry of
(PDF) Preclinical investigations and first-in-human application of 152Tb-PSMA-617 for PET/CT imaging of prostate cancer
177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy
Case-based Approaches: PSMA and Personalized Prostate Cancer Care - Frankis Almaguel
DEICIDE Reportedly Cancels European Tour
The lives of others: Ute Mahler's images of the real East Germany – in pictures
A better way to diagnose and manage neuroendocrine tumors
Sports misery index: Most miserable fan bases in pro sports
FIGURE 2. 177 Lu-3BP-227 planar and SPECT/CT scans of patient 3. (A)...
Historical Photos in Web Archives Gain Vivid New Lives (Published 2009)
Figure 7. MIP (top) and representative sections (bottom) of PET/CT...
Have Sweet Bauhaus Dreams in BauhausLand
Searching for the truth
KATAKLYSM Introduces 'The Heartbeast'
Loan Default Prediction with Berka Dataset
SIX FEET UNDER Frontman Says Band's New Lineup Will Be 'Death Metal Force To Be Dealt With'
MORBID ANGEL – New Album Release Date Confirmed
Fig. 2. Comparison of 18 F-FDG-PET/CT, 90 Y TOF PET/CT, and 90...
ENSLAVED Announce Ruun UK Tour 2006 With ZYKLON, 1349 And KEEP OF KALESSIN
20 great hotels, B&Bs and apartments in Germany
Around Town